News04/09/2019
PAG signs agreement for controlling Hisun BioRay investment
PAG →PAG and Hisun Pharmaceutical announced a final agreement for PAG to acquire 58% of Hisun BioRay, leaving Hisun with 42%. The approximate consideration is omitted, and the signing is not represented as a closing.